Article

Study: rubella vaccine may prevent eye disease

Chicago-The rubella vaccine, originally a method for preventing birth defects that can occur when "German measles" are passed from a pregnant woman to her fetus, may now prevent eye disease.

Chicago-The rubella vaccine, originally a method for preventing birth defects that can occur when "German measles" are passed from a pregnant woman to her fetus, may now prevent eye disease.

Researchers at the University of Illinois, Chicago, believe this may explain the disappearance of a chronic inflammatory eye disease that can cause cataracts, glaucoma, and blindness, according to the study published in the September issue of the American Journal of Ophthalmology.

Researchers looked at cases of Fuch's heterochromic iridocyclitis (FHI) in U.S. and foreign-born babies before and after the vaccination was introduced in the United States. Babies who were born abroad, receiving the vaccine later, showed more occurrences of FHI than American babies who received it earlier.

Although the cause of FHI is unknown, antibodies to the rubella virus have been found in the eyes of FHI patients which according to researchers, suggests a link.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.